Use of the DirecNet Applied Treatment Algorithm (DATA) for diabetes management with a real‐time continuous glucose monitor (the FreeStyle Navigator)

Background:  There are no published guidelines for use of real‐time continuous glucose monitoring data by a patient; we therefore developed the DirecNet Applied Treatment Algorithm (DATA). The DATA provides algorithms for making diabetes management decisions using glucose values: (i) in real time which include the direction and rate of change of glucose levels, and (ii) retrospectively based on downloaded sensor data.

[1]  J. Skyler,et al.  Algorithms for Adjustment of Insulin Dosage by Patients Who Monitor Blood Glucose , 1981, Diabetes Care.

[2]  J Herlitz,et al.  Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. , 1995, Journal of the American College of Cardiology.

[3]  B. Bistrian,et al.  Intensive insulin therapy in critically ill patients. , 2002, The New England journal of medicine.

[4]  Irl B Hirsch,et al.  The rationale and management of hyperglycemia for in-patients with cardiovascular disease: time for change. , 2003, The Journal of clinical endocrinology and metabolism.

[5]  G. Grunkemeier,et al.  Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. , 2003, The Journal of thoracic and cardiovascular surgery.

[6]  J. Chiasson,et al.  The use of information technology for the management of intensive insulin therapy in type 1 diabetes mellitus. , 2003, Diabetes & metabolism.

[7]  G. Van den Berghe How to compare adequacy of algorithms to control blood glucose in the intensive care unit? , 2004, Critical care.

[8]  T. Hara,et al.  Improved diabetes control by using ‘close adjustment algorithms’ , 2004, Pediatrics international : official journal of the Japan Pediatric Society.

[9]  Bruce W Bode,et al.  Glucommander: a computer-directed intravenous insulin system shown to be safe, simple, and effective in 120,618 h of operation. , 2005, Diabetes care.

[10]  R. Beck,et al.  Continuous glucose monitoring in children with type 1 diabetes. , 2007, The Journal of pediatrics.